ELA: motoneurona y no motoneurona

Value of the Information & Strength of the Argument

The value of the information resides in its comprehensive, state-of-the-art overview of ALS aetiology. The speakers present well-documented genetic data (e.g., mutation frequencies, gen‐phenotype correlations) and pathological findings (TDP‐43 inclusions, cryptic exons in STMN2 and UNC13A). They argue from distinct perspectives and critically evaluate each other’s hypotheses. The motor neuron origin is supported by early axonal and synaptic defects in animal models, while the peripheral tissue view is backed by the detection of TDP‐43 in muscle biopsies and pre-symptomatic skin positivity. The roundtable allows direct confrontation of ideas, clarifying that current evidence does not resolve the causality. The argumentation is rigorous, acknowledging uncertainty and the preliminary nature of some findings, which strengthens its scientific value.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigour is high: the speakers are established researchers from University of Tours, University of Strasbourg, and Hospital 12 de Octubre, with peer-reviewed track records. They refer to widely accepted genetic and pathological data and clearly distinguish between established facts (e.g., C9orf72 expansions) and hypotheses (e.g., muscle-driven). Sources are implicitly from the literature; the conference itself is a platform for data presentation, not a peer-reviewed publication, but the content aligns with published research. The title exactly matches the content, which is the motor neuron vs. non-motor neuron debate. No public comments were provided for analysis, so trends cannot be assessed.

The title exactly reflects the central debate of the conference: the motor neuron as the origin vs. peripheral tissues such as muscle as contributors to ALS pathophysiology.

9/10

The session brings together recognized specialists from leading European institutions, with detailed molecular and clinical data from ongoing research. The presentations are consistent with published scientific literature and explicitly highlight robust genetic findings (e.g., C9orf72, SOD1). The debate structure adds critical scrutiny to alternative hypotheses, though some results (e.g., pre-symptomatic TDP-43 skin biopsies) are openly presented as preliminary and not yet peer-reviewed.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 10:00Opening remarks by Raimundo Pérez-Hernández (Fundación Ramón Areces) and Estíbaliz Luzón (Fundación Luzón) establishing the context of the 10th meeting.
• 25:00Alberto García Redondo introduces the audience interactive poll on whether muscle contributes to neurodegeneration, and then starts his talk on the multiple faces of ALS.
• 40:00Alberto García Redondo presents genetic heterogeneity: SOD1 (2%), TARDBP (0.4%), FUS (0.4%), C9orf72 (10%), and more than 40 genes associated with ALS.
• 1:00:00Discussion of TDP-43 pathology in over 97% of patients, including cytoplasmic mislocalization and cryptic exon inclusion in STMN2 and UNC13A.
• 1:20:00Presentation of Scottish biobank findings: TDP-43 positivity in skin biopsies from 17 individuals up to two decades before ALS onset.
• 1:30:00Philippe Corcia argues for the motor neuron origin, detailing early axonopathy and synaptic dysfunction in ALS models.
• 2:00:00José Luis González de Aguilar presents evidence for the role of muscle as a contributor, including muscle-specific changes and retrograde signalling.
• 2:20:00Panel discussion moderated by Ana Cris Calvo Royo, with all speakers debating the relative contribution of motor neuron versus peripheral tissues.
• 2:50:00Closing remarks and acknowledgements of the conference, summarizing the need for collaborative research.

• Event page: ELA: motoneurona y no motoneurona — Official page of the conference, providing the program and registration details.

• Event page: ELA: motoneurona y no motoneurona — The conference provides a transparent agenda and acknowledges both hypotheses, aligning with the discussion.